Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co., Ltd., commonly referred to as Baiyunshan, is a leading player in the traditional Chinese medicine industry, headquartered in Guangzhou, China. Established in 1997, the company has made significant strides in integrating modern technology with traditional practices, positioning itself as a pioneer in the sector. Baiyunshan operates primarily in the Asia-Pacific region, focusing on the research, development, and manufacturing of herbal medicines and health supplements. Its core product offerings include a diverse range of traditional Chinese herbal remedies, which are distinguished by their adherence to quality and efficacy standards. With a strong market presence, Baiyunshan has achieved notable recognition for its commitment to innovation and excellence, making it a trusted name in the field of Chinese medicine. The company continues to expand its influence, contributing to the global appreciation of traditional healing practices.
How does Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co., Ltd.'s score of 20 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co., Ltd., headquartered in China, currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. Additionally, there are no documented reduction targets or climate pledges from the company, indicating a lack of publicly available commitments towards carbon reduction or sustainability initiatives. In the context of the industry, this absence of data and commitments may suggest a need for enhanced transparency and proactive measures in addressing climate change impacts. Overall, without specific emissions data or reduction initiatives, it is challenging to assess Hutchison Whampoa Guangzhou Baiyunshan's current environmental performance or future climate commitments.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.